36
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety

Article: 18 | Received 24 Apr 2020, Accepted 01 May 2020, Published online: 04 Dec 2023

References

  • Canada H Mandatory reporting of serious adverse drug reactions and medical device incidents by hospitals - Overview. In:2019.
  • Organization. WH. International Drug Monitoring: The Role of National Centres. Report of WHO Meeting. Geneva, Switzerland: World Health Organization. ;1971.
  • Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. 2004;170(11):1678–1686.
  • Hazell L, Shakir SA. Under-reporting of adverse drug reactions : a systematic review. Drug Saf. 2006;29(5):385–396.
  • Olsson S, Pal SN, Dodoo A. Pharmacovigilance in resource-limited countries. Expert Rev Clin Pharmacol. 2015;8(4):449–460.
  • Li Q, Zhang SM, Chen HT, et al. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J. 2004;117(6):856–861.
  • Ekman E, Backstrom M. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. Eur J Clin Pharmacol. 2009;65(1):43–46.
  • Responses from the Canadian Society of Hospital Pharmacists to Questions Related to Mandatory Reporting of Adverse Drug Reactions and Medical Device Incidents by Provincial and Territorial Healthcare Institutions. Canadian Society of Hospital Pharmacists, Jan. 2016,.
  • “Medication Incident Data in Canada: A Strategy for More Effective Sharing and Learning.” Medication Incident Data in Canada: A Strategy for More Effective Sharing and Learning, ISMP Canada, 30 Aug. 2017, www.ismp-canada.org/download/safetyBulletins/2017/ISMPCSB2017-07-strategy.pdf.
  • Centers for Disease Control and Prevention (CDC). Information for Clinicians on Therapeutic Options for COVID-19 Patients. https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html. Accessed March 28 2020.
  • 5 Questions to Ask About Your Medications. 5 Questions to Ask - ISMP Canadahttps://www.ismp-canada.org/medrec/5questions.htm (Accessed March 31 2020).